IDEOGEN Group GmbH
Version 1.0 | March 2026
> Note: This Legal Notice is required by Swiss law (UWG/UCA), Austrian law (ECG), Spanish law (LSSI-CE), Dutch law, and German-language website requirements. It is published in compliance with the mandatory disclosure obligations applicable to IDEOGEN Group GmbH and its subsidiaries. Where placeholders appear (e.g., "[KVK: PLACEHOLDER]"), these must be completed with the relevant registered numbers before publication.
The website www.ideogen.com is operated by:
IDEOGEN Group GmbH (Gesellschaft mit beschränkter Haftung — Swiss limited liability company)
Managing Director and Authorized Representative:
H. Tuygan Göker Chief Executive Officer and Chairman IDEOGEN Group GmbH Hurdnerstrasse 119, CH-8640 Hurden SZ, Switzerland Telephone: +41 43 311 52 52 Email: [email protected]
IDEOGEN Group GmbH operates through the following subsidiary and affiliated entities. Each entity is separately registered and regulated in its respective jurisdiction. References to "IDEOGEN" throughout this Legal Notice encompass the group as a whole where applicable, and the specific legal entity where jurisdiction-specific obligations apply.
Applicable Law: Regulated under Dutch law, including the Wet bescherming persoonsgegevens (Wbp) as superseded by the Uitvoeringswet Algemene Verordening Gegevensbescherming (UAVG) and the EU General Data Protection Regulation (GDPR). Pharmaceutical activities in the Netherlands are regulated by the Geneesmiddelenwet (Medicines Act) and supervised by the Inspectie Gezondheidszorg en Jeugd (IGJ).
Applicable Law: Regulated under Spanish law including the Ley 34/2002, de 11 de julio, de servicios de la sociedad de la información y de comercio electrónico (LSSI-CE), the Ley Orgánica 3/2018, de 5 de diciembre, de Protección de Datos Personales y garantía de los derechos digitales (LOPDGDD), and the EU GDPR. Pharmaceutical activities are regulated by the Ley 29/2006, de 26 de julio, de garantías y uso racional de los medicamentos y productos sanitarios and supervised by the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS).
Applicable Law: Regulated under Austrian law including the Bundesgesetz, mit dem bestimmte rechtliche Aspekte des elektronischen Geschäfts- und Rechtsverkehrs geregelt werden (E-Commerce-Gesetz, ECG), Federal Law Gazette I No. 152/2001 as amended, the Datenschutzgesetz (DSG), and the EU GDPR. Pharmaceutical activities are regulated by the Arzneimittelgesetz (AMG) and supervised by the Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH (AGES) / Bundesamt für Sicherheit im Gesundheitswesen (BASG).
Austrian Disclosure pursuant to § 5 ECG (E-Commerce-Gesetz)
Pursuant to § 5 ECG, IDEOGEN GmbH (Austria) discloses the following additional information:
Applicable Law: Turkish operations are subject to the Turkish Personal Data Protection Law (KVKK) No. 6698, the Pharmaceutical Act (İlaç ve Eczacılık Kanunu), and applicable Turkish pharmaceutical regulations supervised by the Turkish Medicines and Medical Devices Agency (TITCK).
Applicable Law: Maltese operations are subject to Maltese law, EU law including the GDPR, and pharmaceutical regulations supervised by the Medicines Authority Malta.
IDEOGEN Group GmbH holds the following licence(s) issued by Swissmedic, the Swiss Agency for Therapeutic Products:
IDEOGEN is authorised to handle sterile injectables, cytotoxic agents, narcotics and controlled substances, biologics, blood and plasma products, medical devices, and Advanced Therapy Medicinal Products (ATMPs) in accordance with its Swissmedic authorisations and applicable Swiss pharmaceutical law.
The Responsible Person for medicinal product distribution activities within IDEOGEN Group GmbH is:
[NAME OF RESPONSIBLE PERSON PLACEHOLDER] IDEOGEN Group GmbH Hurdnerstrasse 119, CH-8640 Hurden SZ, Switzerland Email: [RP EMAIL PLACEHOLDER]
IDEOGEN's pharmacovigilance activities are managed on its behalf by APCER Life Sciences. The Qualified Person for Pharmacovigilance (QPPV) responsible for the oversight of IDEOGEN's pharmacovigilance obligations is:
[NAME OF QPPV PLACEHOLDER] Contact: [email protected] APCER Life Sciences [APCER LIFE SCIENCES ADDRESS]
For adverse event reporting and pharmacovigilance enquiries:
Pursuant to Article 37 of the EU General Data Protection Regulation (GDPR) and applicable national data protection legislation, IDEOGEN has appointed a Data Protection Officer. The Data Protection Officer may be contacted at:
Data Protection Officer [NAME TO BE APPOINTED PLACEHOLDER] IDEOGEN Group GmbH Hurdnerstrasse 119, CH-8640 Hurden SZ, Switzerland Email: [email protected]
Data subjects may contact the DPO directly with any questions regarding IDEOGEN's processing of their personal data, or to exercise their data subject rights under the GDPR and/or the Swiss Federal Act on Data Protection (nFADP/nDSG).
** — Swiss Agency for Therapeutic Products** Hallerstrasse 7 3012 Bern Switzerland
Telephone: +41 58 462 02 11 Website: www.swissmedic.ch Email: [email protected]
Swissmedic is the national competent authority responsible for the authorisation and supervision of therapeutic products (medicinal products and medical devices) in Switzerland under the Swiss Therapeutic Products Act (TPA/HMG, Bundesgesetz über Arzneimittel und Medizinprodukte, SR 812.21).
** (FDPIC)Eidgenössischer Datenschutz- und Öffentlichkeitsbeauftragter, EDÖB*) Feldeggweg 1 3003 Bern Switzerland
Telephone: +41 58 462 43 95 Website: www.edoeb.admin.ch Email: [email protected]
For data subjects located within the European Economic Area, the relevant national data protection supervisory authority for each EU member state in which IDEOGEN operates is also competent. The relevant supervisory authorities include:
IDEOGEN Group GmbH and its subsidiaries operate in compliance with the following primary professional and regulatory frameworks:
IDEOGEN takes reasonable care to ensure that the information published on this website is accurate and up to date at the time of publication. However, IDEOGEN does not warrant or represent that any information on this website is accurate, complete, current, or error-free. Information on this website may be subject to change without notice.
The information contained on this website is provided for general informational purposes only and does not constitute medical advice, professional diagnosis, treatment recommendations, or a substitute for consultation with a qualified healthcare professional. Healthcare professionals and patients should always consult the locally approved prescribing information and seek appropriate professional medical advice.
To the fullest extent permitted by Swiss law, IDEOGEN and its affiliates shall not be liable for any direct, indirect, incidental, special, or consequential loss or damage arising from:
(a) reliance on information contained on this website;
(b) any errors, omissions, or inaccuracies in the information provided; or
(c) interruptions to the availability of this website.
This limitation does not apply to liability for intentional misconduct or gross negligence under the Swiss Code of Obligations (OR), or to any liability that cannot be excluded under mandatory applicable law.
© 2013–2026 IDEOGEN Group GmbH. All rights reserved.
All content on this website, including text, images, graphics, logos, photographs, audio and video materials, and the overall design and layout of the website, is the intellectual property of IDEOGEN Group GmbH or its licensors and is protected by Swiss copyright law (Urheberrechtsgesetz, URG, SR 231.1), the Berne Convention for the Protection of Literary and Artistic Works, and applicable international intellectual property treaties.
No part of this website may be reproduced, distributed, published, transmitted, modified, adapted, translated, or commercially exploited in any form or by any means without the prior written permission of IDEOGEN Group GmbH, except as expressly permitted by applicable mandatory law.
The names "IDEOGEN", "IDEOGEN Group", "Ideogen LABS", and associated logos are registered or unregistered trademarks of IDEOGEN Group GmbH. All other trademarks, brand names, and logos referenced on this website are the property of their respective owners.
For any questions, corrections, or communications relating to this Legal Notice, please contact:
IDEOGEN Group GmbH Legal and Compliance Department Hurdnerstrasse 119 CH-8640 Hurden SZ Switzerland
Email: [email protected] Telephone: +41 43 311 52 52
For data protection and privacy enquiries: [email protected]
For pharmacovigilance reporting: [email protected]
© 2013–2026 IDEOGEN Group GmbH. All rights reserved.
Version 1.0 — March 2026
> Austria (§ 5 ECG): IDEOGEN GmbH (Austria) disclosure obligations under § 5 E-Commerce-Gesetz are addressed in Section 2.3 above. Prior to publication, confirm that all required fields under § 5 ECG are complete, including the FN number, Handelsgericht, and applicable professional regulations. > > Spain (LSSI-CE Art. 10): IDEOGEN LABS SL disclosure obligations under Article 10 of the Ley 34/2002 (LSSI-CE) are addressed in Section 2.2 above. Prior to publication, confirm the CIF, Mercantile Register details, and any sector-specific authorisation numbers are complete. > > Netherlands (Tw Art. 11a): Ideogen LABS B.V. disclosure obligations under Dutch law are addressed in Section 2.1 above. Prior to publication, confirm the KVK number and Dutch VAT number are accurate. > > Switzerland (UWG/UCA): IDEOGEN Group GmbH's identification disclosures in Section 1 above satisfy the requirements of Swiss UWG Art. 3(1)(b) regarding misleading omission of business identity information. Confirm the UID is registered and accurate prior to publication. > > Germany (TMG): While IDEOGEN does not have a German-incorporated entity, this Legal Notice is drafted to satisfy § 5 Telemediengesetz (TMG) requirements for German-speaking website visitors, given that the website is available in German.
